Meds Coupons

View Deals

8 Coupons

  • of all car-t cell trials registered since 2001, more than half are being conducted in china. .
  • eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .
    published on: may 17, 2018 | last updated: may 17, 2018 5:42 pm pdt
  • .